Clinical TrialsSearch results
Number of results: 198
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A randomized trial of lamivudine continuous therapy and entecavir switching therapy for chronic hepatitis B patients treated with lamivudine monotherapy
- Chronic hepatitis B
- Nagoya City University Hospital
- 2008-04-16
Other
- JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan
- hepatoblastoma hepatocellular carcinoma
- Japanese Study Group for Pediatric Liver Tumors
- 2008-04-09
Other
- LOWER NORMAL PRESSURE GLAUCOMA STUDY
- Glaucoma
- Japan Glaucoma Society
- 2008-02-23
Other
- A late phase II study of multidisciplinary approach to establish standard treatment for advanced neuroblastoma
- neuroblastoma
- Japan Neuroblastoma Study Group
- 2008-02-20
Other
- The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
- Essential hypertension
- JATOS Study Group
- 2008-02-15
Other
- A phase II study of oxaliplatin, folinic acid and 5-fluorouracil (modified FOLFOX-6) combination chemotherapy as adjuvant treatment after resection of liver metastases from colorectal cancer
- liver metastases of colorectal cancer
- Miyagi HBPCOG
- 2008-01-25
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid Leukemia
- Acute myeloid Leukemia Myelodysplastic syndrome
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2008-01-22
Other
- Phase 2 study of cisplatin and pemetrexed in previously treated patients with malignant pleural mesothelioma
- Malignant pleural mesothelioma
- Hyogo College of Medicine
- 2008-01-04
Other
- Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
- tachyarrhythmia
- JL-Knight Study Group
- 2007-12-27
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04